Mitsui Chemicals, Inc.
(Correction) “Summary of Consolidated Results for the Second Quarter of Fiscal 2026 (Interim) and Summary of Earnings Forecast for Fiscal 2026”
A correction was made to the summary of consolidated results for the second quarter of fiscal 2026 and the summary of the fiscal 2026 earnings forecast, revising the period for reflecting the impact of the acquisition of Ultradent Products, Inc. to an eight-month period.
Key Figures
- Period of inclusion of impact on consolidated results: 8 months (August 2026–March 2027)
- Correction scope: Range described in the annotation
- Exchange rate: 0.00628 USD/JPY (acquisition date 2026-11-11)
AI要約
Summary of the Correction
This notice communicates a partial correction to the "Summary of Consolidated Results for the Second Quarter of Fiscal 2026 (Interim) and Summary of Earnings Forecast for Fiscal 2026", correcting the described period for the impact of the acquisition of Ultradent Products, Inc. on consolidated results. The correction is noted in the annotation on page 3 of the document, changing the impact period from the previously stated eight months (August 2025–March 2026) to August 2026–March 2027.
Key Points on Forecasts and Impact
The correction amends the assumptions underlying the previously disclosed earnings forecast; specific numerical comparisons between old and new figures are limited to the corrected sections in the document. Changing the timing of the impact on consolidated results may adjust the scope of effect on the fiscal 2026 earnings forecast. Foreign exchange information is provided as a reference.
Mitsui Chemicals, Inc.
Company overview · Stock price · Financial data · All IR
